This inventor holds 1 USPTO granted patent. Top assignee: Tonghua Dongbao Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Zhongyu Zhang in Pharmaceutical Development
Introduction
Zhongyu Zhang is a notable inventor based in Jilin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug formulations. His work is characterized by a focus on improving the stability and efficacy of injectable medications.
Latest Patents
Zhongyu Zhang holds a patent for a "Stable secukinumab injection and preparation method therefor." This innovative formulation includes ingredients such as 50 mg/ml-300 mg/ml of secukinumab, histidine, methionine, a low-sugar alcohol, and polysorbate 80, with water for injection as the balance. The pH of the solution is maintained between 5.0 and 7.0. Stability tests have demonstrated that this formulation is superior to existing commercial varieties, meeting the relevant regulations of the Chinese Pharmacopoeia and showing promising application prospects.
Career Highlights
Zhongyu Zhang is currently associated with Tonghua Dongbao Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the quality of pharmaceutical products available in the market.
Collaborations
Zhongyu Zhang collaborates with various professionals in the pharmaceutical industry, including his coworker, Depeng Wang. Their combined expertise contributes to the innovative projects at their company.
Conclusion
Zhongyu Zhang's contributions to pharmaceutical innovations, particularly through his patent for a stable secukinumab injection, highlight his role as a key inventor in the industry. His work not only improves drug stability but also enhances patient care through better medication options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile